Open

Alcohol-related Liver Disease Study

A study to confirm the safety and effectiveness of a medication to help with alcohol-related liver disease in adults between 18 and 65 years old.

Age & Gender

18 years ~ 65 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

Each study visit will include meeting with study members to complete questionnaires, blood draw, urine sample, vitals, physical exam, and receiving study medicine injection.

Incentives

In-person visits:
22

Total length of participation:
Up to 71 weeks

Looking for Specific Volunteers

Able to participate:

alcohol-related liver disease
Have had an alcoholic drink in the past 4 months

Not eligible if:

Do NOT have alcohol-related liver disease
Have NOT had an alcoholic drink in the past 4 months

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA

Secondary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Hersh Shroff
Medicine-Gastroenterology

Study Type

Clinical or Medical
Interventional

Study Topics

Chronic Conditions
Injury/Injury Prevention
Kidneys and Liver
Substance Use (tobacco, alcohol, opioids, etc)

IRB Number

25-1057

ClinicalTrials.gov

NCT06104319

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.